Roche to buy PathAI for $750 million

FierceBiotechEnterprise reports phase 2 cystic fibrosis win, succeeding where Big Pharma stumbled

LabiotechThe real reason CGT programs struggle to scale

FierceBiotechBristol Myers Squibb inks $15B biobucks deal to bag Hengrui assets, tap China’s R&D speed

eLifeEndogenous corazonin signaling modulates the post-mating switch in behavior and physiology in females of the brown planthopper and <i>Drosophila</i>

IlluminaHow Illumina employees work to move healthcare toward precision medicine - Illumina

AgilentAgilent's top executives join Jefferies healthcare fireside chat June 3 - Stock Titan

AgilentAgilent to Participate in Jefferies Global Healthcare Conference - Business Wire

Endpoints NewsOptum Rx unveils pharmacy model with clear fees, building on transparency push

Thermo FisherThermo Fisher Expands Cell Therapy And Hydration Platforms To Deepen Ecosystem - Yahoo Finance

Clinical OMICsFactors Predicting Poor Outcomes in Hypertrophic Cardiomyopathy Uncovered

Clinical OMICsSlow-Growing Breast Cancer Cells May Explain Why Relapse Happens Decades Later

Clinical OMICsAsthma Drug Formoterol Shows Potential to Reverse MASH